RASIO MONOSIT LIMFOSIT SEBAGAI PREDIKTOR KEPARAHAN NEFROPATI DIABETIK PADA PASIEN DIABETES MELITUS TIPE 2

Authors

  • Andri Bernando Universitas Sumatera Utara
  • Jelita Siregar Universitas Sumatera Utara
  • Santi Syafril Universitas Sumatera Utara

DOI:

https://doi.org/10.34012/jukep.v6i2.4073

Keywords:

type 2 diabetes mellitus, diabetic nephropathy, monocyte-lymphocyte ratio

Abstract

Diabetic nephropathy is a complication that often occurs in diabetics. In this disease, there is damage to the kidney filter, known as the glomerulus. Due to glomerular damage, diabetic nephropathy is closely related to the mechanism of inflammation. The Monocyte-Lymphocyte Ratio is a relatively new marker of inflammation. This study aims to explore the significance of the prediction of the Monocyte-Lymphocyte Ratio as a predictor of the severity of diabetic nephropathy in Type 2 Diabetes Mellitus (DMT2) patients at H. Adam Malik Hospital, Medan. The research was conducted using the cross-section method. This study took blood samples from 44 patients with type 2 diabetes mellitus with diabetic nephropathy, 22 patients with macroalbuminuria, and 22 patients with microalbuminuria. Then blood was drawn from the vein, and the Monocyte-Lymphocyte Ratio was assessed in all patients. In this study, the average MLR for all patients was 0.41±0.037. There was a significant difference between MLR values ​​in diabetic nephropathy patients with macroalbuminuria compared to diabetic nephropathy patients with microalbuminuria (p<0.001). The optimal cut-off value of MLR in predicting diabetic nephropathy with macroalbuminuria and microalbuminuria was 0.37 with a specificity of 81.8% and a sensitivity of 81.8%. The MLR value in type 2 diabetic patients with diabetic nephropathy can be used as a prognostic factor for the incidence of microalbuminuria and macroalbuminuria.

Downloads

Published

2023-08-23

How to Cite

Bernando, A., Siregar, J., & Syafril, S. (2023). RASIO MONOSIT LIMFOSIT SEBAGAI PREDIKTOR KEPARAHAN NEFROPATI DIABETIK PADA PASIEN DIABETES MELITUS TIPE 2. Jurnal Keperawatan Priority, 6(2), 112-118. https://doi.org/10.34012/jukep.v6i2.4073

Issue

Vol. 6 No. 2 (2023)

Section

Articles

License

Copyright (c) 2023 Andri Bernando, Jelita Siregar, Santi Syafril

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish their manuscripts through the Journal of Keperawatan Priority agree to the following:

  • Copyright to the manuscripts of scientific papers in this Journal is held by the author.
  • The author surrenders the rights when first publishing the manuscript of his scientific work and simultaneously the author grants permission / license by referring to the Creative Commons Attribution 4.0 International License to other parties to distribute his scientific work while still giving credit to the author and the Journal of Journal Keperawatan Priority as the first publication medium for the work.
  • Matters relating to the non-exclusivity of the distribution of the Journal that publishes the author's scientific work can be agreed separately (for example: requests to place the work in the library of an institution or publish it as a book) with the author as one of the parties to the agreement and with credit to sJournal ofJournal Keperawatan Priority as the first publication medium for the work in question.
  • Authors can and are expected to publish their work online (e.g. in a Repository or on their Organization's/Institution's website) before and during the manuscript submission process, as such efforts can increase citation exchange earlier and with a wider scope.